MX2018000013A - Composiciones y metodos para diagnosis y tratamiento de anemia. - Google Patents
Composiciones y metodos para diagnosis y tratamiento de anemia.Info
- Publication number
- MX2018000013A MX2018000013A MX2018000013A MX2018000013A MX2018000013A MX 2018000013 A MX2018000013 A MX 2018000013A MX 2018000013 A MX2018000013 A MX 2018000013A MX 2018000013 A MX2018000013 A MX 2018000013A MX 2018000013 A MX2018000013 A MX 2018000013A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- compositions
- anemia
- treatment
- conditions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se proporcionan composiciones que incluyen un ácido graso, tal como un ácido graso de cadena impar o un ácido graso de cadena par muy larga, y sales y derivados de los mismos, y métodos para el tratamiento y profilaxis de condiciones relacionadas a condiciones anémicas, que incluyen composiciones y métodos para tratar condiciones anémicas tal como anemia hemolítica y anemia de enfermedad crónica, y otras condiciones relacionadas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/393,771 US10238618B2 (en) | 2016-12-29 | 2016-12-29 | Compositions and methods for diagnosis and treatment of anemia |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018000013A true MX2018000013A (es) | 2018-11-09 |
Family
ID=61022302
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018000013A MX2018000013A (es) | 2016-12-29 | 2018-01-08 | Composiciones y metodos para diagnosis y tratamiento de anemia. |
MX2020004767A MX2020004767A (es) | 2016-12-29 | 2018-01-08 | Composiciones y metodos para diagnosis y tratamiento de anemia. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020004767A MX2020004767A (es) | 2016-12-29 | 2018-01-08 | Composiciones y metodos para diagnosis y tratamiento de anemia. |
Country Status (7)
Country | Link |
---|---|
US (3) | US10238618B2 (es) |
EP (2) | EP3562481B1 (es) |
JP (1) | JP7037367B2 (es) |
CA (1) | CA3039591A1 (es) |
ES (1) | ES2899635T3 (es) |
MX (2) | MX2018000013A (es) |
WO (1) | WO2018122407A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9561206B2 (en) * | 2015-01-07 | 2017-02-07 | The United States Of America, As Represented By The Secretary Of The Navy | Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabolic syndrome |
US10307388B2 (en) * | 2016-12-29 | 2019-06-04 | The United States Of America As Represented By The Secretary Of The Navy | Compositions and methods for diagnosis and treatment of inflammation |
AU2018354090A1 (en) | 2017-10-23 | 2020-03-12 | Epitracker, Inc. | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome |
WO2019226572A1 (en) | 2018-05-23 | 2019-11-28 | Epitracker, Inc. | Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity |
EP3914242A4 (en) * | 2019-01-23 | 2023-02-01 | Epitracker, Inc. | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF QUALITY OF AGING AND LONGEVITY DISORDERS |
WO2022005879A1 (en) * | 2020-07-01 | 2022-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of treating bone marrow failure syndromes and compositions for use in the same |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR79620E (fr) | 1958-05-29 | 1962-12-28 | Hercules Powder Co Ltd | Polymérisation de composés époxydés |
DE2615061A1 (de) | 1976-04-05 | 1977-10-06 | Wolfgang Dr Med Wagner | Injektionsverfahren und -vorrichtungen |
US4252159A (en) | 1979-04-02 | 1981-02-24 | Maki Eugene B | Dosage device |
DE3501534A1 (de) | 1984-09-22 | 1986-05-15 | Walter Ing.(grad.) 7758 Meersburg Holzer | Verfahren und vorrichtung zum dosieren von insulin oder aehnlichen langzeitmedikamenten |
DE3875075D1 (de) | 1987-11-25 | 1992-11-05 | Siemens Ag | Dosiergeraet zum gesteuerten injizieren von fluessigkeiten aus einem vorratsbehaelter in einen organismus. |
EP0569618B1 (de) | 1992-05-12 | 1997-01-02 | Siemens-Elema AB | Dosiergerät zur gesteuerten Abgabe einer Flüssigkeit |
WO2005113036A1 (en) | 2004-05-13 | 2005-12-01 | The Regents Of The University Of California | Method and apparatus for glucose control and insulin dosing for diabetics |
MX2007000304A (es) * | 2004-07-02 | 2007-06-15 | Baylor Res Inst | Metodo de tratamiento de enfermedad de almacenamiento de glucogeno o polisacaridos. |
US8251904B2 (en) | 2005-06-09 | 2012-08-28 | Roche Diagnostics Operations, Inc. | Device and method for insulin dosing |
US20070203235A1 (en) * | 2006-02-28 | 2007-08-30 | Rosales Francisco J | Method for preventing or treating anemia |
NZ555163A (en) * | 2007-05-14 | 2010-05-28 | Fonterra Co Operative Group | Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments |
DE102007055636A1 (de) | 2007-11-21 | 2009-05-28 | Robert Bosch Gmbh | Medikamenten-Dosiervorrichtung zum Verabreichen eines flüssigen Medikaments |
US20120072236A1 (en) | 2010-08-06 | 2012-03-22 | Benjamin Atkin | Insulin pen data recording and transmission device |
CN203915611U (zh) | 2011-02-09 | 2014-11-05 | 贝克顿·迪金森公司 | 与输注基部附接的套节及用于传送药物的传送系统 |
US9561206B2 (en) * | 2015-01-07 | 2017-02-07 | The United States Of America, As Represented By The Secretary Of The Navy | Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabolic syndrome |
US10307388B2 (en) | 2016-12-29 | 2019-06-04 | The United States Of America As Represented By The Secretary Of The Navy | Compositions and methods for diagnosis and treatment of inflammation |
-
2016
- 2016-12-29 US US15/393,771 patent/US10238618B2/en active Active
-
2018
- 2018-01-02 EP EP18701095.4A patent/EP3562481B1/en active Active
- 2018-01-02 ES ES18701095T patent/ES2899635T3/es active Active
- 2018-01-02 EP EP21189054.6A patent/EP3922244A1/en active Pending
- 2018-01-02 WO PCT/EP2018/050063 patent/WO2018122407A1/en unknown
- 2018-01-02 CA CA3039591A patent/CA3039591A1/en active Pending
- 2018-01-04 JP JP2018000312A patent/JP7037367B2/ja active Active
- 2018-01-08 MX MX2018000013A patent/MX2018000013A/es unknown
- 2018-01-08 MX MX2020004767A patent/MX2020004767A/es unknown
-
2019
- 2019-02-05 US US16/267,570 patent/US20190201362A1/en not_active Abandoned
- 2019-08-07 US US16/534,837 patent/US20200022939A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20190201362A1 (en) | 2019-07-04 |
WO2018122407A1 (en) | 2018-07-05 |
EP3922244A1 (en) | 2021-12-15 |
US20180185315A1 (en) | 2018-07-05 |
US10238618B2 (en) | 2019-03-26 |
JP2018135318A (ja) | 2018-08-30 |
JP7037367B2 (ja) | 2022-03-16 |
EP3562481B1 (en) | 2021-08-25 |
ES2899635T3 (es) | 2022-03-14 |
US20200022939A1 (en) | 2020-01-23 |
MX2020004767A (es) | 2021-08-26 |
CA3039591A1 (en) | 2018-07-05 |
EP3562481A1 (en) | 2019-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018000013A (es) | Composiciones y metodos para diagnosis y tratamiento de anemia. | |
MX2021001091A (es) | Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington. | |
BR112017003658A2 (pt) | composto, mistura, métodos para tratamento de uma doença e para inibição de uma glicosidase, e, composição farmacêutica. | |
SG11201901061QA (en) | Heterocyclic compound | |
EA201891063A1 (ru) | Производные дигидроимидазопиразинона, применимые в лечении рака | |
MY198613A (en) | Nitrobenzyl derivatives of anti-cancer agents | |
CN106536480A8 (zh) | 吡咯烷‑2,5‑二酮衍生物、药物组合物及用作ido1抑制剂的方法 | |
MX2020001757A (es) | Compuestos, sales de los mismos y metodos para el tratamiento de enfermedades. | |
MY197698A (en) | Oxysterols and methods of use thereof | |
CL2015002334A1 (es) | Modificador del sabor dulce | |
EA201491968A1 (ru) | Производные имидазотиадиазола и имидазопиридазина в качестве ингибиторов активируемых протеазой рецепторов 4 (par4) для лечения агрегации тромбоцитов | |
CL2017001650A1 (es) | Derivados de 5-[(piperazina-1-yl)-3-oxo-propilo]-imidazolidina-2,4-dionan como inhibidores adamts para el tratamiento oesteoartritis. | |
EA201791182A1 (ru) | Новые производные 2'- и/или 5'-аминокислотных эфиров фосфороамидатов 3'-дезоксиаденозина в качестве противораковых соединений | |
EA201890767A1 (ru) | C4-модифицированные производные олеаноловой кислоты для ингибирования il-17 и других применений | |
MX370628B (es) | Composiciones y metodos para tratar las espinillas. | |
BR112016021648A2 (pt) | novos compostos | |
PH12017500007A1 (en) | Quinolizinone derivatives as p13k inhibitors | |
BR112018006545A2 (pt) | ?composto, composição farmacêutica, combinação, uso de um composto, e, método para tratamento de uma doença ou condição? | |
EA033342B1 (ru) | Пирролидинкарбоксамидо производные и способы их получения и их применение | |
PH12017501735A1 (en) | Novel heterocyclic compound, method for preparing the same, and pharmaceutical composition comprising the same | |
EA201792264A1 (ru) | Способы лечения воспалительных заболеваний | |
BR112016021656A2 (pt) | inibidores das vias de sinalização de wnt | |
PH12016502568B1 (en) | Novel heterocyclic compound | |
PH12015502746A1 (en) | Prodrug derivatives of substituted triazolopyridines | |
EA201692045A1 (ru) | Производное фенантролинфосфоновой кислоты и способ его получения и применения |